We sought to ascertain the changes in mortality from ischaemic heart disease (IHD) from 2004 to 2010 in China as the sheer size of China's population makes disease patterns relevant globally.
Introduction
Cardiovascular diseases are the leading cause of death worldwide. 1 Currently, .60% of the global burden of ischaemic heart disease (IHD) occurs in developing countries, where 82% of the future increase in mortality is expected to occur. 2, 3 In terms of population, China is the largest country in the world, representing one-fifth of the global population. According to the 2010 census, China had a total population of 1.34 billion with 51% males and 49% females. The population in China is not only ageing, but also there is a trend towards urbanization. In 2000, 64% of China's population was rural and 36% urban. By 2010, the proportions had changed, with approximately half the population considered rural and the other half urban. 4 In addition, the standard of living and life expectancy have increased in China due to economic and social reforms in the last three decades. Concurrently, cardiovascular disease, already the leading cause of death in China, is also expected to increase; economic development, urbanization, and ageing of the population, as outlined above, are major drivers of this trend. 5 Globally, the age-adjusted rates of IHD-related deaths are decreasing. 6 Herein, we present an alarming increase in age-adjusted rates of IHD mortality in China. These changes in the mortality in the world's most populous country have global implications.
Methods

Data acquisition and normalization
We acquired mortality data from the Chinese Centre for Disease Control and Prevention National Disease Surveillance Point System, which includes 161 counties within China, and is a representative sample of the entire Chinese population. 7 Briefly, this surveillance system covers 161 counties (disease surveillance points, DSPs) spread among the 31 provinces of China; among them, 64 DSPs are urban, and 97 DSPs are rural. The geographic area is divided into three regions: East, Central, and West (see Supplementary material online, Methods and Figure S1 ). The total population covered numbers over 73 million, which represents 6% of the entire population in China. The DSPs data are representative at the national, urban, and rural levels based on the evaluation report. The ICD10 codes for IHD included ICD10 I20-I25. The trends for IHD mortality from 2004 to 2010, except the missing year 2006, are described by age, gender, and urban/rural status. To account for the effects of age and to make the data comparable to other datasets, we normalized to the WHO reference population standard. 11 For the mortality rate calculation, we assumed that all people were followed for the whole year and thus has been presented as person-years.
Statistical methodology
Aggregated data on the number of IHD deaths in China were summarized by year, gender, and rurality. Secular trends in IHD mortality between 2004 and 2010 were assessed using negative binomial regression models, where the number of deaths was the outcome (either crude or standardized), and the log (population size) for that year was included as an offset term. Differences in trends between males and females by rurality status were assessed by including a three-way interaction term among sex, rurality, and year (and the lower order twoway interactions, i.e. sex × rurality, sex × year, and rurality × year).
The main comparisons of interest are as follows: (i) the difference in trends for rural vs. urban males, and (ii) the difference in trends for rural vs. urban females. All statistical analyses were programmed using SAS v9.4 (SAS Institute, Cary, NC, USA).
Results
Ischaemic heart disease mortality rates
Crude IHD mortality rates increased in both males and females, in both urban and rural settings from 2004 to 2010 (Tables 1 and 2) . Mortality increased for rural males by 6.5% per year (95% CI: 5.8 -7.3%; P , 0.0001). This increase was significantly higher (P , 0.0001) than urban males by 3.3% per year (95% CI: 2.2 -4.3%; P , 0.0001). Crude IHD mortality rates increased for rural females by 5.0% per year (95% CI: 4.2 -5.7%; P , 0.0001); this trend was statistically significantly higher (P , 0.0001) than urban females by 2.2% per year (95%CI: 1.2 -3.3%; P , 0.0001). The difference between genders in rural vs. urban trend differences was not statistically significant (P ¼ 0.2) ( Table 2 ; see Supplementary material online, Table S1 ).
We then standardized the data to the WHO reference population. WHO-standardized IHD mortality rates increased even more than the crude rates (See Table 1 and Figure 1 ). Ischaemic heart disease mortality increased for rural males by 9.2% per year (95% CI: 6.7 -11.7%; P , 0.0001), and the trend was statistically significantly higher (P ¼ 0.0001) than in urban males by 6.4% per year (95% CI: 3 -10%; P ¼ 0.0001). WHO-standardized IHD mortality rate increased for rural females by 7.0% per year (95% CI: 4.6 -9.4%; P , 0.0001); this was statistically significantly higher (P ¼ 0.01) than urban females by 4.3% per year (95% CI: 1 -8%; P ¼ 0.023). The difference between genders in rural vs. urban trend differences was not statistically significant (P ¼ 0.4). We then examined the mortality rates from acute myocardial infarction from 2004 to 2008 and found the same trends (see Supplementary material online, Table S1 ). Further, the rates of IHD mortality appear to not just be increasing, but to actually be accelerating.
Increasing ischaemic heart disease mortality in older subjects there is a steady increase in mortality rates with .50% rise over the 7-year study period ( Figure 1 ).
Discussion
Our article has some key findings. First, ours is the largest report of IHD mortality trends in a representative cohort of the Chinese population. Second, mortality from IHD is increasing in China, in contrast to advances made in other countries. Third, this increase in mortality is largely driven by increasing IHD mortality in rural subjects and in subjects above 80 years. Consequently, the IHD mortality in China has doubled in the past two decades to .1 million deaths per year. 12 Since the mid-1970s, the rate of death from cardiovascular diseases has declined markedly in high-income countries. In contrast, the incidence of cardiovascular disease is still high in some middleand low-income countries, including China. 13 An increase in IHD mortality in China has been reported previously by Jiang et al.
14 However, their study represented a single city experience of 10 million people. Our data confirm and extend their findings in a population of 73 million that has been demonstrated to be representative of the entire country. The WHO-standardized IHD death rates in our study are much higher than are reported for western countries. For example, in the UK, the absolute IHD mortality was below 400 deaths per 100 000 in the 80-to 84-year-old population in 2010, 15 which is one-eighth of IHD mortality in the same age group in China. Similarly, although cardiac care has improved in China in last few decades, there is still room for improvement when we compare it with western countries. The hospital admission for ST-segment elevation myocardial Figure 1 Ischaemic heart disease (IHD) mortality trends in males and females. (A) Mortality due to ischaemic heart disease increased from 2004 to 2010 in males and females (WHO-standardized) from both urban and rural areas. There is a significantly greater rate of increase in rural populations. The rate of increase in males and females is not significantly different, although males start with higher absolute rates of death. (B) Mortality rates remain steady for those in the younger age groups, but rise dramatically in those 80 and older.
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infarction (STEMI) in China has increased from 3.5 to 15.4 per 100 000 individuals from 2001 to 2010 16 but of concern is the fact that only 55% of total STEMI patients received reperfusion therapy and just over a quarter underwent primary percutaneous coronary intervention (PCI) in China. In contrast, in Europe and USA, reperfusion therapy for STEMI is delivered in .70% cases with median symptom onset to reperfusion times of 3 -4 h (compared with .12 h for China). 17 -19 Not only the demographics, but also the cardiovascular risk factor profile in China has changed in the last few decades. As of 2002, the prevalence of dyslipidaemias in China was 18.6%, meaning that .160 million adults were affected. 20, 21 In 2010, an estimated 28.1%
of adults in China (52.9% of men and 2.4% of women) or .300 million people were current smokers. Among men, the prevalence was highest among those 45-64 years of age (63%) and among rural residents. 22 An additional 740 million non-smokers were exposed to second-hand smoke in public places in China. 23 The prevalence of diabetes rose from 5.5% in 2000 to 11.6% in 2010 showing in part an adverse effect of economic development on human health. 24, 25 There is a high prevalence of metabolic syndrome in China with 16.2% (16.1% in men and 16.6% in women) of adults affected in 2005. 26, 27 This highlights the importance of nationwide awareness and treatment campaigns for non-communicable chronic diseases as they are among the leading causes of disease burden. Currently, China has a literacy rate of over 95%, gross national income per capita of US$ 7400 (upper middle income country) and life expectancy at birth of 75 years. 28 The difference seen in rural and urban mortality from IHD may reflect better quality and more timely treatment availability in urban centres. It may also reflect worse health behaviours and lower socioeconomic status in rural areas. Our article has significant implications for the world's most populous country. Cardiovascular disease in China is expected to increase further by 14% from 2010 to 2030 due to unfavourable trends in the cardiovascular risk factor profile. 29 Significant expansion in acute cardiac care facilities is required, especially in the rural areas, for timely diagnosis and provision of therapy (including primary PCI or fibrinolysis for STEMI). Equally important is the establishment of high-quality continuity of care and efforts at primary and secondary prevention. 30 The 12th National Economic and Social
Development 5-year plan, passed at the National People's Congress conference in March 2011, adopted a resolution calling for the 'full implementation of banning smoking in public places', which is a positive step. 23 Since 2011, the European Society of Cardiology (ESC) has delivered educational programs on multiple occasions at the Great Wall International Conference of Cardiology to support efforts to implement a series of treatment and prevention strategies. 31 Similar international collaboration with other cardiac societies is needed to improve healthcare provision and educate China's citizens to curb the epidemic of cardiovascular disease. Our study has some important limitations. First, estimate of the person-years of follow-up assumes that each person is followed to the end of the year and all the deaths happen at the end of the year; this can result in a slight overestimation of the absolute rate. However, given that we are looking at trends over time and this assumption affects all time points equally, this will not affect the main analysis or results of the paper. Second, we present population-level data, not individual-level data, so we cannot accurately estimate the contributions of different risk factors to increasing IHD mortality in China.
In conclusion, mortality from IHD is increasing in China, in contrast to the western world. This needs urgent attention by the policymakers to curb the epidemic of heart disease.
